版權(quán)說(shuō)明:本文檔由用戶提供并上傳,收益歸屬內(nèi)容提供方,若內(nèi)容存在侵權(quán),請(qǐng)進(jìn)行舉報(bào)或認(rèn)領(lǐng)
文檔簡(jiǎn)介
1、陜西中醫(yī)學(xué)院碩士學(xué)位論文中藥平消栓對(duì)H肝癌移植瘤模型小鼠bcl-2和TNF-α表達(dá)影響的實(shí)驗(yàn)研究姓名:王裕云申請(qǐng)學(xué)位級(jí)別:碩士專業(yè):中西醫(yī)結(jié)合臨床指導(dǎo)教師:孔平孝20100401The Experimental Research of Ping Xiao Suppository Effected The Expression of Bcl-2 and TNF-αin ICR mice Transferred by H22 Abstrac
2、t Objective Objective Through the research of Ping Xiao Suppository to H22 ascites carcinoma tumor lines transfected ICR mice the general projects, immune organs(thymus,spleen),bcl-2 and TNF- α expression of experimenta
3、l studies to explore the possibility of anti-tumor drug mechanism and for the further development of Chinese Medicine in cancer research and provide a theoretical basis. Method Method Based on the randomi
4、zation principle, 40 ICR female mouse divides stochastically into four groups, respectively be the blank control group(group A),the Dutch lump control group(group B), 5-fluorouracil group(group C),the Ping Xiao
5、 Suppository group(group D).Each mouse in The group B, group C and group D has vaccinates the H22 lump cell at the right armpit by the hypodermic to hang fluid 0.2ml.After 24 hours, weigh each mice and start to abd
6、ominal cavity injection to give the medicine. Group A and B use physiological saline 0.2ml/ each /every day(continuously to give medicine 14 days). Group C use 5-fluorouracil 25mg/kg, dilutes the density to mg/
7、0.2ml (give medicine D1-D5), Group D use Ping Xiao Suppository which dissolved in the physiological saline, 1.0g/kg (continuously to give medicine 14 days). Daily observation of mice eating, drinking, activitie
8、s, mental state, such as hair color and death, a detailed record of changes in average body weight in mice drawing curves. Dislocation execution the mouse at the 15th day, take the tumor tissue, thymus, spleen
溫馨提示
- 1. 本站所有資源如無(wú)特殊說(shuō)明,都需要本地電腦安裝OFFICE2007和PDF閱讀器。圖紙軟件為CAD,CAXA,PROE,UG,SolidWorks等.壓縮文件請(qǐng)下載最新的WinRAR軟件解壓。
- 2. 本站的文檔不包含任何第三方提供的附件圖紙等,如果需要附件,請(qǐng)聯(lián)系上傳者。文件的所有權(quán)益歸上傳用戶所有。
- 3. 本站RAR壓縮包中若帶圖紙,網(wǎng)頁(yè)內(nèi)容里面會(huì)有圖紙預(yù)覽,若沒有圖紙預(yù)覽就沒有圖紙。
- 4. 未經(jīng)權(quán)益所有人同意不得將文件中的內(nèi)容挪作商業(yè)或盈利用途。
- 5. 眾賞文庫(kù)僅提供信息存儲(chǔ)空間,僅對(duì)用戶上傳內(nèi)容的表現(xiàn)方式做保護(hù)處理,對(duì)用戶上傳分享的文檔內(nèi)容本身不做任何修改或編輯,并不能對(duì)任何下載內(nèi)容負(fù)責(zé)。
- 6. 下載文件中如有侵權(quán)或不適當(dāng)內(nèi)容,請(qǐng)與我們聯(lián)系,我們立即糾正。
- 7. 本站不保證下載資源的準(zhǔn)確性、安全性和完整性, 同時(shí)也不承擔(dān)用戶因使用這些下載資源對(duì)自己和他人造成任何形式的傷害或損失。
最新文檔
- 中藥平消栓對(duì)H-,22-肝癌移植瘤模型小鼠Fas和MMP-9表達(dá)影響的實(shí)驗(yàn)研究.pdf
- 中藥平消栓對(duì)H-,22-瘤株移植瘤小鼠TGFβ-,1-和IL-8影響的實(shí)驗(yàn)研究.pdf
- 三奇注射液對(duì)H-,22-肝癌移植瘤bcl-2和bax基因表達(dá)影響的實(shí)驗(yàn)研究.pdf
- 扶正抗癌湯對(duì)H-,22-肝癌模型小鼠TNF-α及IL-2的影響.pdf
- 山仙顆粒對(duì)荷H-,22-肝癌小鼠TNF-α和IL-6影響的實(shí)驗(yàn)研究.pdf
- 靈芪膠囊對(duì)H-,22-荷瘤小鼠的抑瘤作用及其對(duì)p53和bcl-2蛋白表達(dá)的影響.pdf
- 扶正抗癌方對(duì)H-,22-腹水型瘤株移植瘤小鼠FAS和FASL表達(dá)影響的實(shí)驗(yàn)研究.pdf
- 培元抗癌湯對(duì)H22瘤株移植瘤小鼠Bax和Bcl-2癌基因表達(dá)影響的實(shí)驗(yàn)研究.pdf
- 扶正抗癌方對(duì)H-,22-腹水型瘤株移植瘤小鼠Survivin和NF-κB表達(dá)影響的實(shí)驗(yàn)研究.pdf
- 三奇注射液對(duì)小鼠H-,22-肝癌移植瘤突變型P53和PCNA表達(dá)影響的實(shí)驗(yàn)研究.pdf
- 平消栓對(duì)肝癌小鼠ki-67和VEGF表達(dá)影響的實(shí)驗(yàn)研究.pdf
- 山仙顆粒對(duì)H-,22-腹水型瘤株移植瘤小鼠bFGF和FGFR1影響的實(shí)驗(yàn)研究.pdf
- 裴氏軟肝消痞丸對(duì)小鼠移植性肝癌H22瘤組織中P27及Bcl-2蛋白表達(dá)的影響.pdf
- 鬼針草煎劑對(duì)H-,22-肝癌荷瘤小鼠抑瘤率及免疫功能影響的實(shí)驗(yàn)研究.pdf
- 山仙顆粒對(duì)H-,22-肝癌小鼠NK細(xì)胞活性及抑瘤率影響的實(shí)驗(yàn)研究.pdf
- 平調(diào)飲對(duì)H-,22-肝癌腹水瘤荷瘤小鼠抗腫瘤作用的實(shí)驗(yàn)研究.pdf
- 山仙顆粒對(duì)H-,22-腹水型瘤株移植瘤小鼠IGF-Ⅱ和IGF-ⅡR影響的實(shí)驗(yàn)研究.pdf
- 供者淋巴細(xì)胞輸注治療小鼠H-,22-肝癌皮下移植瘤的實(shí)驗(yàn)研究.pdf
- 冬凌草醇提物對(duì)荷H-,22-瘤小鼠抑瘤的實(shí)驗(yàn)研究.pdf
- 山仙顆粒對(duì)H-,22-肝癌瘤株轉(zhuǎn)染的氣虛血瘀型ICR小鼠COX—2影響的實(shí)驗(yàn)研究.pdf
評(píng)論
0/150
提交評(píng)論